This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Siemens U.S. Sales Up 18% In 4th Quarter 2012

Siemens AG (NYSE: SI) today announced strong results for the fourth quarter of fiscal 2012 and achieved its outlook for the year. "A strong fourth quarter enabled us to fulfill our expectations for fiscal 2012 and achieve one of our best years ever. Even so, we didn’t fully succeed in significantly boosting our performance vis-à-vis our competitors, as we did in recent years. To get back to reaching our own goals, we've launched Siemens 2014, a company-wide program aimed at raising our Total Sectors profit margin to at least 12 percent. We know what we have to do – and we’re doing it," said Siemens CEO and President Peter Loescher.

In the U.S., on an adjusted basis, sales were up 18% to approximately $5.5 billion (€4.4 billion) and orders were down 2% to roughly $5.1 billion (€4.1 billion) over the last quarter. In fiscal 2012 sales rose 16% to approximately $21.6 billion (€16.7 billion) and orders were down 2% to approximately $20.0 billion (€15.4 billion) on an adjusted basis.

The Energy Sector of Siemens received a major order for the IPP Qurayyah combined-cycle power plant in Saudi Arabia. The billion dollar order, which will be fulfilled out of Siemens Charlotte manufacturing facilities, will supply enough electrical energy to meet about one-tenth of the country's current power demand. This year, Siemens won a multi-million dollar order for a high-efficiency power plant in Temple, Texas, to supply a natural-gas-fired combined-cycle power plant for the Panda Temple Power Project, which will be among the cleanest fossil-fueled plants in the U.S. Siemens also received a large onshore wind turbine order from MidAmerican Energy Company for a 407-megawatt wind project expansion. These turbines, once completed, will provide renewable energy for more than 120,000 average U.S. households.

Siemens Healthcare launched this year its comprehensive imaging solution for the visualization and quantification of amyloid plaques – a necessary pathological feature of Alzheimer’s disease – in the living brain. This imaging solution includes the new Biograph™ mCT positron emission tomography/computed tomography (PET•CT) scanner, syngo®.PET Amyloid Plaque software, which enables the physician to target regions of interest in the living brain, and the radiopharmaceutical production expertise of PETNET Solutions, a wholly-owned subsidiary of Siemens. This combination of scanner, software and radiopharmaceutical production provides U.S. physicians with valuable tools for the evaluation of Alzheimer’s disease and other causes of cognitive decline.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.21 -0.44%
FB $117.80 -0.22%
GOOG $701.26 0.80%
YHOO $36.94 2.60%
TSLA $211.34 -5.00%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs